nodes	percent_of_prediction	percent_of_DWPC	metapath
Acebutolol—ABCB1—lung cancer	0.281	1	CbGaD
Acebutolol—ABCB1—Topotecan—lung cancer	0.0436	0.0995	CbGbCtD
Acebutolol—ABCB1—Gefitinib—lung cancer	0.0399	0.091	CbGbCtD
Acebutolol—CYP2D6—Gefitinib—lung cancer	0.0376	0.0857	CbGbCtD
Acebutolol—ABCB1—Vinorelbine—lung cancer	0.0307	0.0701	CbGbCtD
Acebutolol—CYP2D6—Vinorelbine—lung cancer	0.029	0.066	CbGbCtD
Acebutolol—ABCB1—Crizotinib—lung cancer	0.0245	0.0558	CbGbCtD
Acebutolol—ABCB1—Gemcitabine—lung cancer	0.0239	0.0545	CbGbCtD
Acebutolol—ABCB1—Erlotinib—lung cancer	0.0236	0.0538	CbGbCtD
Acebutolol—CYP2D6—Erlotinib—lung cancer	0.0222	0.0507	CbGbCtD
Acebutolol—ABCB1—Paclitaxel—lung cancer	0.0216	0.0492	CbGbCtD
Acebutolol—ABCB1—Irinotecan—lung cancer	0.0213	0.0486	CbGbCtD
Acebutolol—ABCB1—Vinblastine—lung cancer	0.0189	0.0432	CbGbCtD
Acebutolol—CYP2D6—Vinblastine—lung cancer	0.0179	0.0407	CbGbCtD
Acebutolol—ABCB1—Cisplatin—lung cancer	0.0174	0.0396	CbGbCtD
Acebutolol—ABCB1—Etoposide—lung cancer	0.0171	0.0389	CbGbCtD
Acebutolol—ABCB1—Docetaxel—lung cancer	0.0156	0.0356	CbGbCtD
Acebutolol—ABCB1—Doxorubicin—lung cancer	0.0116	0.0265	CbGbCtD
Acebutolol—ABCB1—Methotrexate—lung cancer	0.0113	0.0257	CbGbCtD
Acebutolol—CYP2D6—Doxorubicin—lung cancer	0.011	0.025	CbGbCtD
Acebutolol—Anorexia—Etoposide—lung cancer	0.000146	0.000663	CcSEcCtD
Acebutolol—Skin disorder—Paclitaxel—lung cancer	0.000146	0.000663	CcSEcCtD
Acebutolol—Body temperature increased—Irinotecan—lung cancer	0.000146	0.000661	CcSEcCtD
Acebutolol—Abdominal pain—Irinotecan—lung cancer	0.000146	0.000661	CcSEcCtD
Acebutolol—Aspartate aminotransferase increased—Doxorubicin—lung cancer	0.000146	0.000661	CcSEcCtD
Acebutolol—Decreased appetite—Cisplatin—lung cancer	0.000146	0.00066	CcSEcCtD
Acebutolol—Hyperhidrosis—Paclitaxel—lung cancer	0.000145	0.000659	CcSEcCtD
Acebutolol—Pneumonia—Methotrexate—lung cancer	0.000145	0.000657	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Cisplatin—lung cancer	0.000145	0.000656	CcSEcCtD
Acebutolol—Drowsiness—Methotrexate—lung cancer	0.000144	0.000653	CcSEcCtD
Acebutolol—Depression—Methotrexate—lung cancer	0.000144	0.000652	CcSEcCtD
Acebutolol—Anorexia—Paclitaxel—lung cancer	0.000143	0.00065	CcSEcCtD
Acebutolol—Hypotension—Etoposide—lung cancer	0.000143	0.00065	CcSEcCtD
Acebutolol—Pain—Cisplatin—lung cancer	0.000143	0.000649	CcSEcCtD
Acebutolol—Vomiting—Vinorelbine—lung cancer	0.000142	0.000645	CcSEcCtD
Acebutolol—Body temperature increased—Gemcitabine—lung cancer	0.000142	0.000644	CcSEcCtD
Acebutolol—Rash—Vinorelbine—lung cancer	0.000141	0.000639	CcSEcCtD
Acebutolol—Dermatitis—Vinorelbine—lung cancer	0.000141	0.000639	CcSEcCtD
Acebutolol—Hypotension—Paclitaxel—lung cancer	0.000141	0.000637	CcSEcCtD
Acebutolol—Headache—Vinorelbine—lung cancer	0.00014	0.000635	CcSEcCtD
Acebutolol—Syncope—Docetaxel—lung cancer	0.00014	0.000635	CcSEcCtD
Acebutolol—Conjunctivitis—Methotrexate—lung cancer	0.00014	0.000635	CcSEcCtD
Acebutolol—Sweating—Methotrexate—lung cancer	0.000138	0.000626	CcSEcCtD
Acebutolol—Palpitations—Docetaxel—lung cancer	0.000138	0.000626	CcSEcCtD
Acebutolol—Feeling abnormal—Cisplatin—lung cancer	0.000138	0.000626	CcSEcCtD
Acebutolol—Paraesthesia—Etoposide—lung cancer	0.000138	0.000625	CcSEcCtD
Acebutolol—Loss of consciousness—Docetaxel—lung cancer	0.000137	0.000623	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000137	0.000622	CcSEcCtD
Acebutolol—Dyspnoea—Etoposide—lung cancer	0.000137	0.00062	CcSEcCtD
Acebutolol—Somnolence—Etoposide—lung cancer	0.000136	0.000619	CcSEcCtD
Acebutolol—Cough—Docetaxel—lung cancer	0.000136	0.000618	CcSEcCtD
Acebutolol—Insomnia—Paclitaxel—lung cancer	0.000136	0.000617	CcSEcCtD
Acebutolol—Paraesthesia—Paclitaxel—lung cancer	0.000135	0.000613	CcSEcCtD
Acebutolol—Agranulocytosis—Methotrexate—lung cancer	0.000134	0.00061	CcSEcCtD
Acebutolol—Dyspnoea—Paclitaxel—lung cancer	0.000134	0.000608	CcSEcCtD
Acebutolol—Somnolence—Paclitaxel—lung cancer	0.000134	0.000606	CcSEcCtD
Acebutolol—Decreased appetite—Etoposide—lung cancer	0.000133	0.000605	CcSEcCtD
Acebutolol—Arthralgia—Docetaxel—lung cancer	0.000133	0.000603	CcSEcCtD
Acebutolol—Myalgia—Docetaxel—lung cancer	0.000133	0.000603	CcSEcCtD
Acebutolol—Chest pain—Docetaxel—lung cancer	0.000133	0.000603	CcSEcCtD
Acebutolol—Nausea—Vinorelbine—lung cancer	0.000133	0.000602	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Etoposide—lung cancer	0.000132	0.000601	CcSEcCtD
Acebutolol—Dyspepsia—Paclitaxel—lung cancer	0.000132	0.0006	CcSEcCtD
Acebutolol—Body temperature increased—Cisplatin—lung cancer	0.000132	0.0006	CcSEcCtD
Acebutolol—Asthenia—Irinotecan—lung cancer	0.000132	0.0006	CcSEcCtD
Acebutolol—Fatigue—Etoposide—lung cancer	0.000132	0.0006	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	0.000132	0.000599	CcSEcCtD
Acebutolol—Pain—Etoposide—lung cancer	0.000131	0.000595	CcSEcCtD
Acebutolol—Constipation—Etoposide—lung cancer	0.000131	0.000595	CcSEcCtD
Acebutolol—Dysuria—Doxorubicin—lung cancer	0.000131	0.000593	CcSEcCtD
Acebutolol—Decreased appetite—Paclitaxel—lung cancer	0.000131	0.000593	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Paclitaxel—lung cancer	0.00013	0.000589	CcSEcCtD
Acebutolol—Fatigue—Paclitaxel—lung cancer	0.00013	0.000588	CcSEcCtD
Acebutolol—Asthenia—Gemcitabine—lung cancer	0.000129	0.000585	CcSEcCtD
Acebutolol—Pain—Paclitaxel—lung cancer	0.000129	0.000583	CcSEcCtD
Acebutolol—Constipation—Paclitaxel—lung cancer	0.000129	0.000583	CcSEcCtD
Acebutolol—Confusional state—Docetaxel—lung cancer	0.000129	0.000583	CcSEcCtD
Acebutolol—Pharyngitis—Methotrexate—lung cancer	0.000128	0.000582	CcSEcCtD
Acebutolol—Oedema—Docetaxel—lung cancer	0.000127	0.000578	CcSEcCtD
Acebutolol—Weight increased—Doxorubicin—lung cancer	0.000127	0.000578	CcSEcCtD
Acebutolol—Pruritus—Gemcitabine—lung cancer	0.000127	0.000576	CcSEcCtD
Acebutolol—Feeling abnormal—Etoposide—lung cancer	0.000126	0.000573	CcSEcCtD
Acebutolol—Diarrhoea—Irinotecan—lung cancer	0.000126	0.000572	CcSEcCtD
Acebutolol—Pneumonia—Doxorubicin—lung cancer	0.000125	0.000569	CcSEcCtD
Acebutolol—Gastrointestinal pain—Etoposide—lung cancer	0.000125	0.000569	CcSEcCtD
Acebutolol—Shock—Docetaxel—lung cancer	0.000125	0.000569	CcSEcCtD
Acebutolol—Nervous system disorder—Docetaxel—lung cancer	0.000125	0.000567	CcSEcCtD
Acebutolol—Drowsiness—Doxorubicin—lung cancer	0.000125	0.000566	CcSEcCtD
Acebutolol—Visual impairment—Methotrexate—lung cancer	0.000125	0.000565	CcSEcCtD
Acebutolol—Feeling abnormal—Paclitaxel—lung cancer	0.000124	0.000562	CcSEcCtD
Acebutolol—Skin disorder—Docetaxel—lung cancer	0.000124	0.000562	CcSEcCtD
Acebutolol—Gastrointestinal pain—Paclitaxel—lung cancer	0.000123	0.000558	CcSEcCtD
Acebutolol—Diarrhoea—Gemcitabine—lung cancer	0.000123	0.000557	CcSEcCtD
Acebutolol—Dizziness—Irinotecan—lung cancer	0.000122	0.000553	CcSEcCtD
Acebutolol—Urticaria—Etoposide—lung cancer	0.000122	0.000553	CcSEcCtD
Acebutolol—Anorexia—Docetaxel—lung cancer	0.000122	0.000551	CcSEcCtD
Acebutolol—Abdominal pain—Etoposide—lung cancer	0.000121	0.00055	CcSEcCtD
Acebutolol—Body temperature increased—Etoposide—lung cancer	0.000121	0.00055	CcSEcCtD
Acebutolol—Conjunctivitis—Doxorubicin—lung cancer	0.000121	0.00055	CcSEcCtD
Acebutolol—Tinnitus—Methotrexate—lung cancer	0.000121	0.000547	CcSEcCtD
Acebutolol—Asthenia—Cisplatin—lung cancer	0.00012	0.000545	CcSEcCtD
Acebutolol—Sweating—Doxorubicin—lung cancer	0.00012	0.000542	CcSEcCtD
Acebutolol—Urticaria—Paclitaxel—lung cancer	0.000119	0.000542	CcSEcCtD
Acebutolol—Hypotension—Docetaxel—lung cancer	0.000119	0.00054	CcSEcCtD
Acebutolol—Abdominal pain—Paclitaxel—lung cancer	0.000119	0.000539	CcSEcCtD
Acebutolol—Body temperature increased—Paclitaxel—lung cancer	0.000119	0.000539	CcSEcCtD
Acebutolol—Angiopathy—Methotrexate—lung cancer	0.000117	0.000532	CcSEcCtD
Acebutolol—Vomiting—Irinotecan—lung cancer	0.000117	0.000532	CcSEcCtD
Acebutolol—Mediastinal disorder—Methotrexate—lung cancer	0.000117	0.000529	CcSEcCtD
Acebutolol—Agranulocytosis—Doxorubicin—lung cancer	0.000116	0.000528	CcSEcCtD
Acebutolol—Rash—Irinotecan—lung cancer	0.000116	0.000527	CcSEcCtD
Acebutolol—Dermatitis—Irinotecan—lung cancer	0.000116	0.000527	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Docetaxel—lung cancer	0.000116	0.000527	CcSEcCtD
Acebutolol—Chills—Methotrexate—lung cancer	0.000116	0.000526	CcSEcCtD
Acebutolol—Headache—Irinotecan—lung cancer	0.000116	0.000524	CcSEcCtD
Acebutolol—Insomnia—Docetaxel—lung cancer	0.000115	0.000523	CcSEcCtD
Acebutolol—Diarrhoea—Cisplatin—lung cancer	0.000115	0.00052	CcSEcCtD
Acebutolol—Paraesthesia—Docetaxel—lung cancer	0.000114	0.000519	CcSEcCtD
Acebutolol—Alopecia—Methotrexate—lung cancer	0.000114	0.000518	CcSEcCtD
Acebutolol—Vomiting—Gemcitabine—lung cancer	0.000114	0.000518	CcSEcCtD
Acebutolol—Bradycardia—Doxorubicin—lung cancer	0.000114	0.000517	CcSEcCtD
Acebutolol—Dyspnoea—Docetaxel—lung cancer	0.000114	0.000515	CcSEcCtD
Acebutolol—Somnolence—Docetaxel—lung cancer	0.000113	0.000514	CcSEcCtD
Acebutolol—Rash—Gemcitabine—lung cancer	0.000113	0.000514	CcSEcCtD
Acebutolol—Dermatitis—Gemcitabine—lung cancer	0.000113	0.000513	CcSEcCtD
Acebutolol—Headache—Gemcitabine—lung cancer	0.000113	0.00051	CcSEcCtD
Acebutolol—Rhinitis—Doxorubicin—lung cancer	0.000112	0.000509	CcSEcCtD
Acebutolol—Dyspepsia—Docetaxel—lung cancer	0.000112	0.000509	CcSEcCtD
Acebutolol—Hypoaesthesia—Doxorubicin—lung cancer	0.000111	0.000505	CcSEcCtD
Acebutolol—Pharyngitis—Doxorubicin—lung cancer	0.000111	0.000504	CcSEcCtD
Acebutolol—Decreased appetite—Docetaxel—lung cancer	0.000111	0.000503	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Docetaxel—lung cancer	0.00011	0.000499	CcSEcCtD
Acebutolol—Asthenia—Etoposide—lung cancer	0.00011	0.000499	CcSEcCtD
Acebutolol—Connective tissue disorder—Doxorubicin—lung cancer	0.00011	0.000499	CcSEcCtD
Acebutolol—Fatigue—Docetaxel—lung cancer	0.00011	0.000499	CcSEcCtD
Acebutolol—Nausea—Irinotecan—lung cancer	0.00011	0.000497	CcSEcCtD
Acebutolol—Constipation—Docetaxel—lung cancer	0.000109	0.000494	CcSEcCtD
Acebutolol—Pain—Docetaxel—lung cancer	0.000109	0.000494	CcSEcCtD
Acebutolol—Back pain—Methotrexate—lung cancer	0.000109	0.000494	CcSEcCtD
Acebutolol—Pruritus—Etoposide—lung cancer	0.000109	0.000492	CcSEcCtD
Acebutolol—Visual impairment—Doxorubicin—lung cancer	0.000108	0.000489	CcSEcCtD
Acebutolol—Asthenia—Paclitaxel—lung cancer	0.000108	0.000489	CcSEcCtD
Acebutolol—Atenolol—ABCB1—lung cancer	0.000107	0.343	CrCbGaD
Acebutolol—Nausea—Gemcitabine—lung cancer	0.000107	0.000484	CcSEcCtD
Acebutolol—Vomiting—Cisplatin—lung cancer	0.000106	0.000483	CcSEcCtD
Acebutolol—Pruritus—Paclitaxel—lung cancer	0.000106	0.000483	CcSEcCtD
Acebutolol—Vision blurred—Methotrexate—lung cancer	0.000106	0.000481	CcSEcCtD
Acebutolol—Rash—Cisplatin—lung cancer	0.000106	0.000479	CcSEcCtD
Acebutolol—Dermatitis—Cisplatin—lung cancer	0.000105	0.000478	CcSEcCtD
Acebutolol—Feeling abnormal—Docetaxel—lung cancer	0.000105	0.000476	CcSEcCtD
Acebutolol—Diarrhoea—Etoposide—lung cancer	0.000105	0.000476	CcSEcCtD
Acebutolol—Ill-defined disorder—Methotrexate—lung cancer	0.000104	0.000474	CcSEcCtD
Acebutolol—Tinnitus—Doxorubicin—lung cancer	0.000104	0.000474	CcSEcCtD
Acebutolol—Gastrointestinal pain—Docetaxel—lung cancer	0.000104	0.000473	CcSEcCtD
Acebutolol—Flushing—Doxorubicin—lung cancer	0.000104	0.000471	CcSEcCtD
Acebutolol—Diarrhoea—Paclitaxel—lung cancer	0.000103	0.000467	CcSEcCtD
Acebutolol—Angiopathy—Doxorubicin—lung cancer	0.000102	0.000461	CcSEcCtD
Acebutolol—Malaise—Methotrexate—lung cancer	0.000102	0.00046	CcSEcCtD
Acebutolol—Dizziness—Etoposide—lung cancer	0.000101	0.00046	CcSEcCtD
Acebutolol—Vertigo—Methotrexate—lung cancer	0.000101	0.000459	CcSEcCtD
Acebutolol—Mediastinal disorder—Doxorubicin—lung cancer	0.000101	0.000458	CcSEcCtD
Acebutolol—Abdominal pain—Docetaxel—lung cancer	0.000101	0.000457	CcSEcCtD
Acebutolol—Body temperature increased—Docetaxel—lung cancer	0.000101	0.000457	CcSEcCtD
Acebutolol—Chills—Doxorubicin—lung cancer	0.0001	0.000456	CcSEcCtD
Acebutolol—Dizziness—Paclitaxel—lung cancer	9.94e-05	0.000451	CcSEcCtD
Acebutolol—Nausea—Cisplatin—lung cancer	9.94e-05	0.000451	CcSEcCtD
Acebutolol—Alopecia—Doxorubicin—lung cancer	9.89e-05	0.000449	CcSEcCtD
Acebutolol—Cough—Methotrexate—lung cancer	9.82e-05	0.000446	CcSEcCtD
Acebutolol—Vomiting—Etoposide—lung cancer	9.75e-05	0.000442	CcSEcCtD
Acebutolol—Rash—Etoposide—lung cancer	9.67e-05	0.000439	CcSEcCtD
Acebutolol—Dermatitis—Etoposide—lung cancer	9.66e-05	0.000438	CcSEcCtD
Acebutolol—Headache—Etoposide—lung cancer	9.61e-05	0.000436	CcSEcCtD
Acebutolol—Flatulence—Doxorubicin—lung cancer	9.61e-05	0.000436	CcSEcCtD
Acebutolol—Myalgia—Methotrexate—lung cancer	9.58e-05	0.000435	CcSEcCtD
Acebutolol—Arthralgia—Methotrexate—lung cancer	9.58e-05	0.000435	CcSEcCtD
Acebutolol—Chest pain—Methotrexate—lung cancer	9.58e-05	0.000435	CcSEcCtD
Acebutolol—Vomiting—Paclitaxel—lung cancer	9.56e-05	0.000434	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	9.52e-05	0.000432	CcSEcCtD
Acebutolol—Rash—Paclitaxel—lung cancer	9.48e-05	0.00043	CcSEcCtD
Acebutolol—Dermatitis—Paclitaxel—lung cancer	9.47e-05	0.00043	CcSEcCtD
Acebutolol—Discomfort—Methotrexate—lung cancer	9.47e-05	0.00043	CcSEcCtD
Acebutolol—Back pain—Doxorubicin—lung cancer	9.43e-05	0.000428	CcSEcCtD
Acebutolol—Headache—Paclitaxel—lung cancer	9.42e-05	0.000427	CcSEcCtD
Acebutolol—Confusional state—Methotrexate—lung cancer	9.26e-05	0.00042	CcSEcCtD
Acebutolol—Vision blurred—Doxorubicin—lung cancer	9.19e-05	0.000417	CcSEcCtD
Acebutolol—Asthenia—Docetaxel—lung cancer	9.15e-05	0.000415	CcSEcCtD
Acebutolol—Nausea—Etoposide—lung cancer	9.11e-05	0.000413	CcSEcCtD
Acebutolol—Ill-defined disorder—Doxorubicin—lung cancer	9.04e-05	0.00041	CcSEcCtD
Acebutolol—Pruritus—Docetaxel—lung cancer	9.02e-05	0.000409	CcSEcCtD
Acebutolol—Nervous system disorder—Methotrexate—lung cancer	9.01e-05	0.000409	CcSEcCtD
Acebutolol—Nausea—Paclitaxel—lung cancer	8.93e-05	0.000405	CcSEcCtD
Acebutolol—Skin disorder—Methotrexate—lung cancer	8.92e-05	0.000405	CcSEcCtD
Acebutolol—Hyperhidrosis—Methotrexate—lung cancer	8.88e-05	0.000403	CcSEcCtD
Acebutolol—Malaise—Doxorubicin—lung cancer	8.79e-05	0.000399	CcSEcCtD
Acebutolol—Vertigo—Doxorubicin—lung cancer	8.76e-05	0.000397	CcSEcCtD
Acebutolol—Anorexia—Methotrexate—lung cancer	8.76e-05	0.000397	CcSEcCtD
Acebutolol—Syncope—Doxorubicin—lung cancer	8.74e-05	0.000397	CcSEcCtD
Acebutolol—Diarrhoea—Docetaxel—lung cancer	8.72e-05	0.000396	CcSEcCtD
Acebutolol—Palpitations—Doxorubicin—lung cancer	8.61e-05	0.000391	CcSEcCtD
Acebutolol—Hypotension—Methotrexate—lung cancer	8.58e-05	0.000389	CcSEcCtD
Acebutolol—Loss of consciousness—Doxorubicin—lung cancer	8.57e-05	0.000389	CcSEcCtD
Acebutolol—Cough—Doxorubicin—lung cancer	8.51e-05	0.000386	CcSEcCtD
Acebutolol—Dizziness—Docetaxel—lung cancer	8.43e-05	0.000382	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Methotrexate—lung cancer	8.37e-05	0.00038	CcSEcCtD
Acebutolol—Metoprolol—ABCB1—lung cancer	8.35e-05	0.267	CrCbGaD
Acebutolol—Insomnia—Methotrexate—lung cancer	8.31e-05	0.000377	CcSEcCtD
Acebutolol—Arthralgia—Doxorubicin—lung cancer	8.3e-05	0.000376	CcSEcCtD
Acebutolol—Chest pain—Doxorubicin—lung cancer	8.3e-05	0.000376	CcSEcCtD
Acebutolol—Myalgia—Doxorubicin—lung cancer	8.3e-05	0.000376	CcSEcCtD
Acebutolol—Anxiety—Doxorubicin—lung cancer	8.27e-05	0.000375	CcSEcCtD
Acebutolol—Paraesthesia—Methotrexate—lung cancer	8.25e-05	0.000374	CcSEcCtD
Acebutolol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	8.24e-05	0.000374	CcSEcCtD
Acebutolol—Discomfort—Doxorubicin—lung cancer	8.2e-05	0.000372	CcSEcCtD
Acebutolol—Dyspnoea—Methotrexate—lung cancer	8.19e-05	0.000372	CcSEcCtD
Acebutolol—Somnolence—Methotrexate—lung cancer	8.17e-05	0.00037	CcSEcCtD
Acebutolol—Vomiting—Docetaxel—lung cancer	8.1e-05	0.000368	CcSEcCtD
Acebutolol—Dyspepsia—Methotrexate—lung cancer	8.09e-05	0.000367	CcSEcCtD
Acebutolol—Rash—Docetaxel—lung cancer	8.04e-05	0.000365	CcSEcCtD
Acebutolol—Dermatitis—Docetaxel—lung cancer	8.03e-05	0.000364	CcSEcCtD
Acebutolol—Confusional state—Doxorubicin—lung cancer	8.02e-05	0.000364	CcSEcCtD
Acebutolol—Decreased appetite—Methotrexate—lung cancer	7.99e-05	0.000362	CcSEcCtD
Acebutolol—Headache—Docetaxel—lung cancer	7.99e-05	0.000362	CcSEcCtD
Acebutolol—Oedema—Doxorubicin—lung cancer	7.96e-05	0.000361	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Methotrexate—lung cancer	7.93e-05	0.00036	CcSEcCtD
Acebutolol—Propranolol—CYP1A1—lung cancer	7.93e-05	0.254	CrCbGaD
Acebutolol—Fatigue—Methotrexate—lung cancer	7.92e-05	0.000359	CcSEcCtD
Acebutolol—Pain—Methotrexate—lung cancer	7.86e-05	0.000356	CcSEcCtD
Acebutolol—Shock—Doxorubicin—lung cancer	7.83e-05	0.000355	CcSEcCtD
Acebutolol—Nervous system disorder—Doxorubicin—lung cancer	7.8e-05	0.000354	CcSEcCtD
Acebutolol—Skin disorder—Doxorubicin—lung cancer	7.73e-05	0.000351	CcSEcCtD
Acebutolol—Hyperhidrosis—Doxorubicin—lung cancer	7.69e-05	0.000349	CcSEcCtD
Acebutolol—Anorexia—Doxorubicin—lung cancer	7.58e-05	0.000344	CcSEcCtD
Acebutolol—Nausea—Docetaxel—lung cancer	7.57e-05	0.000343	CcSEcCtD
Acebutolol—Feeling abnormal—Methotrexate—lung cancer	7.57e-05	0.000343	CcSEcCtD
Acebutolol—Gastrointestinal pain—Methotrexate—lung cancer	7.51e-05	0.000341	CcSEcCtD
Acebutolol—Hypotension—Doxorubicin—lung cancer	7.43e-05	0.000337	CcSEcCtD
Acebutolol—Urticaria—Methotrexate—lung cancer	7.3e-05	0.000331	CcSEcCtD
Acebutolol—Abdominal pain—Methotrexate—lung cancer	7.26e-05	0.000329	CcSEcCtD
Acebutolol—Body temperature increased—Methotrexate—lung cancer	7.26e-05	0.000329	CcSEcCtD
Acebutolol—Musculoskeletal discomfort—Doxorubicin—lung cancer	7.25e-05	0.000329	CcSEcCtD
Acebutolol—Insomnia—Doxorubicin—lung cancer	7.2e-05	0.000326	CcSEcCtD
Acebutolol—Paraesthesia—Doxorubicin—lung cancer	7.14e-05	0.000324	CcSEcCtD
Acebutolol—Dyspnoea—Doxorubicin—lung cancer	7.09e-05	0.000322	CcSEcCtD
Acebutolol—Somnolence—Doxorubicin—lung cancer	7.07e-05	0.000321	CcSEcCtD
Acebutolol—Dyspepsia—Doxorubicin—lung cancer	7e-05	0.000318	CcSEcCtD
Acebutolol—Decreased appetite—Doxorubicin—lung cancer	6.92e-05	0.000314	CcSEcCtD
Acebutolol—Gastrointestinal disorder—Doxorubicin—lung cancer	6.87e-05	0.000312	CcSEcCtD
Acebutolol—Fatigue—Doxorubicin—lung cancer	6.86e-05	0.000311	CcSEcCtD
Acebutolol—Constipation—Doxorubicin—lung cancer	6.8e-05	0.000309	CcSEcCtD
Acebutolol—Pain—Doxorubicin—lung cancer	6.8e-05	0.000309	CcSEcCtD
Acebutolol—Asthenia—Methotrexate—lung cancer	6.59e-05	0.000299	CcSEcCtD
Acebutolol—Feeling abnormal—Doxorubicin—lung cancer	6.56e-05	0.000297	CcSEcCtD
Acebutolol—Gastrointestinal pain—Doxorubicin—lung cancer	6.51e-05	0.000295	CcSEcCtD
Acebutolol—Pruritus—Methotrexate—lung cancer	6.5e-05	0.000295	CcSEcCtD
Acebutolol—Urticaria—Doxorubicin—lung cancer	6.32e-05	0.000287	CcSEcCtD
Acebutolol—Abdominal pain—Doxorubicin—lung cancer	6.29e-05	0.000285	CcSEcCtD
Acebutolol—Body temperature increased—Doxorubicin—lung cancer	6.29e-05	0.000285	CcSEcCtD
Acebutolol—Diarrhoea—Methotrexate—lung cancer	6.29e-05	0.000285	CcSEcCtD
Acebutolol—Dizziness—Methotrexate—lung cancer	6.08e-05	0.000276	CcSEcCtD
Acebutolol—Vomiting—Methotrexate—lung cancer	5.84e-05	0.000265	CcSEcCtD
Acebutolol—Rash—Methotrexate—lung cancer	5.79e-05	0.000263	CcSEcCtD
Acebutolol—Dermatitis—Methotrexate—lung cancer	5.79e-05	0.000263	CcSEcCtD
Acebutolol—Headache—Methotrexate—lung cancer	5.76e-05	0.000261	CcSEcCtD
Acebutolol—Asthenia—Doxorubicin—lung cancer	5.71e-05	0.000259	CcSEcCtD
Acebutolol—Pruritus—Doxorubicin—lung cancer	5.63e-05	0.000255	CcSEcCtD
Acebutolol—Nausea—Methotrexate—lung cancer	5.46e-05	0.000248	CcSEcCtD
Acebutolol—Diarrhoea—Doxorubicin—lung cancer	5.44e-05	0.000247	CcSEcCtD
Acebutolol—Dizziness—Doxorubicin—lung cancer	5.26e-05	0.000239	CcSEcCtD
Acebutolol—Vomiting—Doxorubicin—lung cancer	5.06e-05	0.000229	CcSEcCtD
Acebutolol—Rash—Doxorubicin—lung cancer	5.02e-05	0.000228	CcSEcCtD
Acebutolol—Dermatitis—Doxorubicin—lung cancer	5.01e-05	0.000227	CcSEcCtD
Acebutolol—Headache—Doxorubicin—lung cancer	4.98e-05	0.000226	CcSEcCtD
Acebutolol—Nausea—Doxorubicin—lung cancer	4.73e-05	0.000214	CcSEcCtD
Acebutolol—Propranolol—ABCB1—lung cancer	4.21e-05	0.135	CrCbGaD
Acebutolol—ADRB1—Signaling Pathways—JUNB—lung cancer	1.77e-05	0.000295	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—POMC—lung cancer	1.76e-05	0.000294	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTA4—lung cancer	1.74e-05	0.000291	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTA1—lung cancer	1.74e-05	0.00029	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JUNB—lung cancer	1.73e-05	0.000289	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	1.72e-05	0.000288	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ABCC3—lung cancer	1.72e-05	0.000287	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CG—lung cancer	1.72e-05	0.000286	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—STK11—lung cancer	1.7e-05	0.000284	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTA2—lung cancer	1.7e-05	0.000283	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CG—lung cancer	1.68e-05	0.00028	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKR1C1—lung cancer	1.67e-05	0.000278	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CD—lung cancer	1.66e-05	0.000277	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTA1—lung cancer	1.64e-05	0.000273	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—POMC—lung cancer	1.63e-05	0.000273	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CD—lung cancer	1.63e-05	0.000271	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCC3—lung cancer	1.62e-05	0.00027	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—UGT1A1—lung cancer	1.62e-05	0.00027	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STK11—lung cancer	1.61e-05	0.000268	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—POMC—lung cancer	1.6e-05	0.000267	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6R—lung cancer	1.59e-05	0.000266	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	1.58e-05	0.000264	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTP1—lung cancer	1.58e-05	0.000263	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STK11—lung cancer	1.57e-05	0.000262	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKR1C1—lung cancer	1.57e-05	0.000262	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6R—lung cancer	1.56e-05	0.00026	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GNG11—lung cancer	1.56e-05	0.00026	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FOXO3—lung cancer	1.55e-05	0.000259	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CAT—lung cancer	1.53e-05	0.000256	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	1.53e-05	0.000256	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—UGT1A1—lung cancer	1.52e-05	0.000254	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MAP2K1—lung cancer	1.52e-05	0.000253	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FOXO3—lung cancer	1.52e-05	0.000253	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CD—lung cancer	1.51e-05	0.000252	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ABCB1—lung cancer	1.49e-05	0.000249	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MAP2K1—lung cancer	1.49e-05	0.000248	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALDOA—lung cancer	1.48e-05	0.000248	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CD—lung cancer	1.48e-05	0.000246	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	1.47e-05	0.000246	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GNG11—lung cancer	1.47e-05	0.000245	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—TYMS—lung cancer	1.47e-05	0.000244	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AVP—lung cancer	1.45e-05	0.000242	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—GSTM1—lung cancer	1.45e-05	0.000242	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CB—lung cancer	1.45e-05	0.000242	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NCOA3—lung cancer	1.44e-05	0.00024	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AVP—lung cancer	1.42e-05	0.000237	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CB—lung cancer	1.42e-05	0.000236	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ADCY1—lung cancer	1.4e-05	0.000234	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ABCG2—lung cancer	1.4e-05	0.000234	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALDOA—lung cancer	1.4e-05	0.000233	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IGF1R—lung cancer	1.4e-05	0.000233	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—CXCL8—lung cancer	1.39e-05	0.000232	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—HPGDS—lung cancer	1.37e-05	0.000229	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ENO2—lung cancer	1.37e-05	0.000229	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HES1—lung cancer	1.37e-05	0.000229	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CYP1A1—lung cancer	1.37e-05	0.000229	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IGF1R—lung cancer	1.37e-05	0.000228	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PPP2R1B—lung cancer	1.37e-05	0.000228	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ERCC2—lung cancer	1.36e-05	0.000227	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—CXCL8—lung cancer	1.36e-05	0.000227	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NCOA3—lung cancer	1.36e-05	0.000226	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—RAF1—lung cancer	1.35e-05	0.000225	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HES1—lung cancer	1.34e-05	0.000224	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTT1—lung cancer	1.33e-05	0.000222	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—IL2—lung cancer	1.33e-05	0.000222	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ADCY1—lung cancer	1.32e-05	0.00022	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCG2—lung cancer	1.32e-05	0.00022	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—RAF1—lung cancer	1.32e-05	0.00022	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GCLC—lung cancer	1.32e-05	0.00022	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2A6—lung cancer	1.32e-05	0.00022	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CB—lung cancer	1.32e-05	0.000219	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—IL2—lung cancer	1.3e-05	0.000217	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ENO2—lung cancer	1.3e-05	0.000216	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—HPGDS—lung cancer	1.3e-05	0.000216	CbGpPWpGaD
Acebutolol—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	1.29e-05	0.000216	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.29e-05	0.000215	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CB—lung cancer	1.29e-05	0.000215	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—CXCL8—lung cancer	1.26e-05	0.000211	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTT1—lung cancer	1.26e-05	0.00021	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ERBB3—lung cancer	1.26e-05	0.000209	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ENO1—lung cancer	1.25e-05	0.000208	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	1.25e-05	0.000208	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GCLC—lung cancer	1.24e-05	0.000207	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP2A6—lung cancer	1.24e-05	0.000207	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—CXCL8—lung cancer	1.24e-05	0.000206	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ERBB3—lung cancer	1.23e-05	0.000205	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL2—lung cancer	1.21e-05	0.000202	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TERT—lung cancer	1.2e-05	0.000201	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL2—lung cancer	1.18e-05	0.000197	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—APOA1—lung cancer	1.18e-05	0.000197	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TERT—lung cancer	1.18e-05	0.000196	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ENO1—lung cancer	1.18e-05	0.000196	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—FGFR1—lung cancer	1.17e-05	0.000195	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	1.17e-05	0.000195	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HIF1A—lung cancer	1.15e-05	0.000192	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—FGFR1—lung cancer	1.14e-05	0.000191	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HIF1A—lung cancer	1.13e-05	0.000188	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP2E1—lung cancer	1.12e-05	0.000187	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APOA1—lung cancer	1.11e-05	0.000185	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—NQO1—lung cancer	1.11e-05	0.000185	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KDR—lung cancer	1.1e-05	0.000184	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APOA1—lung cancer	1.09e-05	0.000181	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KDR—lung cancer	1.08e-05	0.00018	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CG—lung cancer	1.08e-05	0.000179	CbGpPWpGaD
Acebutolol—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	1.06e-05	0.000176	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP2E1—lung cancer	1.06e-05	0.000176	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—NQO1—lung cancer	1.04e-05	0.000174	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—POMC—lung cancer	1.02e-05	0.000171	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KIT—lung cancer	1.01e-05	0.000169	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CG—lung cancer	1.01e-05	0.000169	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—APC—lung cancer	1.01e-05	0.000169	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—NRAS—lung cancer	1.01e-05	0.000169	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGF—lung cancer	1e-05	0.000167	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—STK11—lung cancer	9.99e-06	0.000167	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—CREBBP—lung cancer	9.97e-06	0.000166	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CG—lung cancer	9.92e-06	0.000165	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KIT—lung cancer	9.92e-06	0.000165	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—APC—lung cancer	9.92e-06	0.000165	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—NRAS—lung cancer	9.92e-06	0.000165	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGF—lung cancer	9.81e-06	0.000164	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—MAPK3—lung cancer	9.71e-06	0.000162	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—POMC—lung cancer	9.65e-06	0.000161	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—BRAF—lung cancer	9.53e-06	0.000159	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—MAPK3—lung cancer	9.5e-06	0.000158	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CD—lung cancer	9.46e-06	0.000158	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—POMC—lung cancer	9.44e-06	0.000158	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6R—lung cancer	9.42e-06	0.000157	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—STK11—lung cancer	9.41e-06	0.000157	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CREBBP—lung cancer	9.4e-06	0.000157	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—ALB—lung cancer	9.34e-06	0.000156	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—BRAF—lung cancer	9.32e-06	0.000156	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTP1—lung cancer	9.24e-06	0.000154	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—EGFR—lung cancer	9.24e-06	0.000154	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6R—lung cancer	9.21e-06	0.000154	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CREBBP—lung cancer	9.2e-06	0.000153	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—EGFR—lung cancer	9.04e-06	0.000151	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CAT—lung cancer	8.99e-06	0.00015	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAP2K1—lung cancer	8.97e-06	0.00015	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CD—lung cancer	8.92e-06	0.000149	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—PIK3CA—lung cancer	8.83e-06	0.000147	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAP2K1—lung cancer	8.78e-06	0.000146	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—KRAS—lung cancer	8.73e-06	0.000146	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CD—lung cancer	8.72e-06	0.000145	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTP1—lung cancer	8.71e-06	0.000145	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—PIK3CA—lung cancer	8.64e-06	0.000144	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—TYMS—lung cancer	8.59e-06	0.000143	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—KRAS—lung cancer	8.54e-06	0.000142	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—GSTM1—lung cancer	8.49e-06	0.000142	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CAT—lung cancer	8.47e-06	0.000141	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CB—lung cancer	8.24e-06	0.000137	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ABCB1—lung cancer	8.24e-06	0.000137	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTGS2—lung cancer	8.17e-06	0.000136	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—TYMS—lung cancer	8.09e-06	0.000135	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CYP1A1—lung cancer	8.05e-06	0.000134	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—PIK3CA—lung cancer	8.02e-06	0.000134	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—GSTM1—lung cancer	8e-06	0.000133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MDM2—lung cancer	7.99e-06	0.000133	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ERCC2—lung cancer	7.98e-06	0.000133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—RAF1—lung cancer	7.96e-06	0.000133	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—ERBB2—lung cancer	7.87e-06	0.000131	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—PIK3CA—lung cancer	7.84e-06	0.000131	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MDM2—lung cancer	7.81e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—RAF1—lung cancer	7.79e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CB—lung cancer	7.77e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MTOR—lung cancer	7.77e-06	0.00013	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—ERBB2—lung cancer	7.7e-06	0.000128	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CB—lung cancer	7.6e-06	0.000127	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MTOR—lung cancer	7.6e-06	0.000127	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CYP1A1—lung cancer	7.59e-06	0.000127	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ERCC2—lung cancer	7.52e-06	0.000125	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CXCL8—lung cancer	7.47e-06	0.000125	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—HRAS—lung cancer	7.42e-06	0.000124	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CXCL8—lung cancer	7.3e-06	0.000122	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—HRAS—lung cancer	7.26e-06	0.000121	CbGpPWpGaD
Acebutolol—ADRB1—GPCR downstream signaling—AKT1—lung cancer	7.21e-06	0.00012	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CASP3—lung cancer	7.15e-06	0.000119	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL2—lung cancer	7.14e-06	0.000119	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PTEN—lung cancer	7.12e-06	0.000119	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—IL6—lung cancer	7.1e-06	0.000118	CbGpPWpGaD
Acebutolol—ADRB2—GPCR downstream signaling—AKT1—lung cancer	7.06e-06	0.000118	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CASP3—lung cancer	6.99e-06	0.000117	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL2—lung cancer	6.98e-06	0.000116	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CCND1—lung cancer	6.96e-06	0.000116	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—IL6—lung cancer	6.95e-06	0.000116	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—JUN—lung cancer	6.94e-06	0.000116	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—APOA1—lung cancer	6.91e-06	0.000115	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CCND1—lung cancer	6.81e-06	0.000114	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—EP300—lung cancer	6.79e-06	0.000113	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—JUN—lung cancer	6.79e-06	0.000113	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MMP9—lung cancer	6.75e-06	0.000113	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—CDKN1A—lung cancer	6.73e-06	0.000112	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PTEN—lung cancer	6.71e-06	0.000112	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MMP9—lung cancer	6.61e-06	0.00011	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—CDKN1A—lung cancer	6.58e-06	0.00011	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PTEN—lung cancer	6.57e-06	0.00011	CbGpPWpGaD
Acebutolol—ADRB1—Signaling by GPCR—AKT1—lung cancer	6.55e-06	0.000109	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—APOA1—lung cancer	6.51e-06	0.000109	CbGpPWpGaD
Acebutolol—ADRB2—Signaling by GPCR—AKT1—lung cancer	6.41e-06	0.000107	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EP300—lung cancer	6.4e-06	0.000107	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CG—lung cancer	6.31e-06	0.000105	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EP300—lung cancer	6.26e-06	0.000104	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—SRC—lung cancer	6.23e-06	0.000104	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—SRC—lung cancer	6.09e-06	0.000102	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—VEGFA—lung cancer	6.07e-06	0.000101	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—STAT3—lung cancer	6.01e-06	0.0001	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—POMC—lung cancer	6e-06	0.0001	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—NRAS—lung cancer	5.99e-06	9.99e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CG—lung cancer	5.94e-06	9.91e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—VEGFA—lung cancer	5.93e-06	9.9e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—STAT3—lung cancer	5.87e-06	9.8e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—NRAS—lung cancer	5.86e-06	9.77e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—CREBBP—lung cancer	5.85e-06	9.75e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MAPK3—lung cancer	5.74e-06	9.57e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—POMC—lung cancer	5.66e-06	9.43e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MAPK3—lung cancer	5.61e-06	9.36e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—MYC—lung cancer	5.58e-06	9.31e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CD—lung cancer	5.54e-06	9.25e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—CREBBP—lung cancer	5.51e-06	9.19e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—ALB—lung cancer	5.47e-06	9.13e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—MYC—lung cancer	5.46e-06	9.11e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—EGFR—lung cancer	5.46e-06	9.1e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—EGFR—lung cancer	5.34e-06	8.91e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CD—lung cancer	5.22e-06	8.71e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—KRAS—lung cancer	5.16e-06	8.6e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—ALB—lung cancer	5.16e-06	8.6e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—KRAS—lung cancer	5.04e-06	8.41e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—PIK3CA—lung cancer	5.02e-06	8.38e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CB—lung cancer	4.83e-06	8.06e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTGS2—lung cancer	4.79e-06	7.98e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—PIK3CA—lung cancer	4.74e-06	7.9e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—PIK3CA—lung cancer	4.63e-06	7.73e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—TP53—lung cancer	4.58e-06	7.64e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CB—lung cancer	4.55e-06	7.59e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTGS2—lung cancer	4.51e-06	7.52e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—TP53—lung cancer	4.48e-06	7.48e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—HRAS—lung cancer	4.38e-06	7.31e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—HRAS—lung cancer	4.29e-06	7.15e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—IL6—lung cancer	4.19e-06	7e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PTEN—lung cancer	4.17e-06	6.96e-05	CbGpPWpGaD
Acebutolol—SLC22A1—Metabolism—AKT1—lung cancer	4.1e-06	6.85e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—IL6—lung cancer	4.1e-06	6.84e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—EP300—lung cancer	3.98e-06	6.64e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PTEN—lung cancer	3.93e-06	6.56e-05	CbGpPWpGaD
Acebutolol—ADRB1—Signaling Pathways—AKT1—lung cancer	3.87e-06	6.45e-05	CbGpPWpGaD
Acebutolol—ADRB2—Signaling Pathways—AKT1—lung cancer	3.79e-06	6.31e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—EP300—lung cancer	3.75e-06	6.26e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—PIK3CA—lung cancer	2.95e-06	4.91e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—PIK3CA—lung cancer	2.78e-06	4.63e-05	CbGpPWpGaD
Acebutolol—ABCB1—Metabolism—AKT1—lung cancer	2.41e-06	4.01e-05	CbGpPWpGaD
Acebutolol—CYP2D6—Metabolism—AKT1—lung cancer	2.27e-06	3.78e-05	CbGpPWpGaD
